Skip to content
Review

Innovative Technologies in Social

· 0 citations · 22 references

TL;DR

The understanding of autoimmune thyroid diseases continues to evolve and although current therapeutic options effectively manage hormonal dysfunction, they do not directly address the underlying autoimmune process.

View source

Similar papers

Review Open access Sep 2026

AUTOIMMUNE THYROID DISEASES: A COMPREHENSIVE LITERATURE REVIEW OF TREATMENT AND THE CURRENT STATE OF KNOWLEDGE

Introduction and Purpose: Autoimmune thyroid diseases (AITDs) are among the most common organ-specific autoimmune disorders worldwide. The two major forms, Hashimoto's thyroiditis and Graves' disease, result from a complex interaction between genetic susceptibility, environmental triggers, and immune dysregulation. The...

K. Nycz, Julia Knap, Natalia Kitala et al. · 0 citations
Open access Nov 2026

Hashimoto’s thyroiditis: pathophysiology and therapy

Hashimoto’s thyroiditis (HT) is the leading cause of hypothyroidism in iodine-sufficient regions, and it is the most frequent autoimmune thyroid diseases (AITD), comprising also Graves’ disease. HT is associated with thyroid autoantibodies, such as thyroid peroxidase (AbTPO) and thyroglobulin (AbTg) antibodies, that ar...

S. Ferrari, G. Elia, F. Ragusa et al. · 0 citations
Open access Sep 2026

Lifestyle and socioeconomic determinants of autoimmune activity in newly diagnosed Hashimoto’s thyroiditis

Lifestyle behaviors were closely linked to subjective health, while socioeconomic vulnerability was associated with higher anti-TG antibody levels in untreated HT patients, suggesting that financial insecurity, lower level of education, and unstable employment may be related to increased autoimmune reactivity.

B. Levterova, D. Tomov · 0 citations
Open access Sep 2026

Integrated Immune-Endocrine Biomarker Framework for Differentiating Thyroid Dysfunction in Women

Autoimmune thyroid diseases are the result of multiple interactions among inflammatory cytokines, thyroid autoantibodies, and endocrine dysregulation. However, these biomarkers are commonly studied one by one, and it is not possible to appreciate how immune-endocrine axes collectively discriminate between a hyperthyroi...

Aveen M. Asaad, I. S. Kakey · 0 citations
Review Oct 2026

Hashimoto's thyroiditis: two decades on.

This Review synthesises developments over the past two decades in the epidemiology, natural history, aetiopathogenesis, diagnosis, and management of Hashimoto's thyroiditis, and considers emerging mechanistic insights and approaches to precision medicine that might inform future disease-modifying therapies.

Leonidas H. Duntas, G. Effraimidis · 0 citations
Review Open access 2026

Systemic chronic low-grade inflammation and the development of thyroid autoantibodies: Immunological mechanisms and biomarker perspectives

Thyroid autoantibodies, chiefly antibodies against thyroid peroxidase (TPOAb), thyroglobulin (TgAb), and the thyroid-stimulating hormone receptor (TRAb), are central serological hallmarks of autoimmune thyroid disease (AITD). Their presence may precede overt hypothyroidism or hyperthyroidism by years, yet the systemic...

Chao-Jun Teng, Li-Kun Du · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.